SCICLONE PHARMACEUTICALS INC Revenue
SCICLONE PHARMACEUTICALS INC reported Revenue of $44.52 million for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2017-08-09
- SCICLONE PHARMACEUTICALS INC revenues for the quarter ending 2017-06-30 was $44.52M, a 14.18% increase year-over-year.
- SCICLONE PHARMACEUTICALS INC revenues for the quarter ending 2017-03-31 was $42.89M, a 17.52% increase year-over-year.
- SCICLONE PHARMACEUTICALS INC revenues for the quarter ending 2016-12-31 was $44.06M, a 2.80% increase year-over-year.
- SCICLONE PHARMACEUTICALS INC revenues for the quarter ending 2016-09-30 was $40.54M, a 5.45% decline year-over-year.
- SCICLONE PHARMACEUTICALS INC revenues for fiscal 2016 was $160.10M, a 1.81% increase from fiscal 2015.
- SCICLONE PHARMACEUTICALS INC revenues for fiscal 2015 was $157.26M, a 16.67% increase from fiscal 2014.
- SCICLONE PHARMACEUTICALS INC revenues for fiscal 2014 was $134.79M, a 6.09% increase from fiscal 2013.
- SCICLONE PHARMACEUTICALS INC revenues for fiscal 2013 was $127.06M, a 18.69% decline from fiscal 2012.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-06-30 | $44.52M 10-Q · filed 2017-08-09 | $87.41M 10-Q · filed 2017-08-09 | $131.47M derived: sum of 3 quarters · filed 2017-08-09 | $172.02M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2017-03-31 | $42.89M 10-Q · filed 2017-05-10 | $86.95M derived: sum of 2 quarters · filed 2017-05-10 | $127.50M derived: sum of 3 quarters · filed 2017-05-10 | $166.49M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-12-31 | $44.06M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $84.61M derived: sum of 2 quarters · filed 2017-03-09 | $123.60M derived: sum of 3 quarters · filed 2017-08-09 | $160.10M 10-K · filed 2017-03-09 | ||||
| 2016-09-30 | $40.54M 10-Q · filed 2016-11-09 | $79.53M derived: sum of 2 quarters · filed 2017-08-09 | $116.03M 10-Q · filed 2016-11-09 | $158.90M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-06-30 | $38.99M 10-Q · filed 2017-08-09 | $75.49M 10-Q · filed 2017-08-09 | $118.35M derived: sum of 3 quarters · filed 2017-08-09 | $161.23M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2016-03-31 | $36.50M 10-Q · filed 2017-05-10 | $79.36M derived: sum of 2 quarters · filed 2017-05-10 | $122.24M derived: sum of 3 quarters · filed 2017-05-10 | $160.19M derived: sum of 4 quarters · filed 2017-05-10 | ||||
| 2015-12-31 | $42.86M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $85.74M derived: sum of 2 quarters · filed 2017-03-09 | $123.69M derived: sum of 3 quarters · filed 2017-03-09 | $157.26M 10-K · filed 2017-03-09 | ||||
| 2015-09-30 | $42.88M 10-Q · filed 2016-11-09 | $80.83M derived: sum of 2 quarters · filed 2016-11-09 | $114.39M 10-Q · filed 2016-11-09 | $155.82M derived: sum of 4 quarters · filed 2017-03-09 | ||||
| 2015-06-30 | $37.95M 10-Q · filed 2016-08-09 | $71.51M 10-Q · filed 2016-08-09 | $112.94M derived: sum of 3 quarters · filed 2017-03-09 | $147.23M derived: sum of 4 quarters · filed 2017-03-09 | ||||
| 2015-03-31 | $33.57M 10-Q · filed 2016-05-10 | $74.99M derived: sum of 2 quarters · filed 2017-03-09 | $109.28M derived: sum of 3 quarters · filed 2017-03-09 | $141.79M derived: sum of 4 quarters · filed 2017-03-09 | ||||
| 2014-12-31 | $41.42M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $75.71M derived: sum of 2 quarters · filed 2017-03-09 | $108.22M derived: sum of 3 quarters · filed 2017-03-09 | $134.79M 10-K · filed 2017-03-09 | ||||
| 2014-09-30 | $34.29M 10-Q · filed 2015-11-09 | $66.80M derived: sum of 2 quarters · filed 2015-11-09 | $93.36M 10-Q · filed 2015-11-09 | $126.10M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-06-30 | $32.51M 10-Q · filed 2015-08-10 | $59.08M 10-Q · filed 2015-08-10 | $91.81M derived: sum of 3 quarters · filed 2016-03-11 | $127.04M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-03-31 | $26.57M 10-Q · filed 2015-05-11 | $59.30M derived: sum of 2 quarters · filed 2016-03-11 | $94.53M derived: sum of 3 quarters · filed 2016-03-11 | $123.82M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2013-12-31 | $32.73M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $67.96M derived: sum of 2 quarters · filed 2016-03-11 | $97.25M derived: sum of 3 quarters · filed 2016-03-11 | $127.06M 10-K · filed 2016-03-11 | ||||
| 2013-09-30 | $35.23M 10-Q · filed 2014-11-10 | $64.52M derived: sum of 2 quarters · filed 2014-11-10 | $94.32M 10-Q · filed 2014-11-10 | $127.46M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | $29.29M 10-Q · filed 2014-08-11 | $59.10M 10-Q · filed 2014-08-11 | $92.24M derived: sum of 3 quarters · filed 2015-03-12 | $132.93M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | $29.81M 10-Q · filed 2014-05-12 | $62.95M derived: sum of 2 quarters · filed 2015-03-12 | $103.64M derived: sum of 3 quarters · filed 2015-03-12 | $145.01M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | $33.14M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $73.83M derived: sum of 2 quarters · filed 2015-03-12 | $115.20M derived: sum of 3 quarters · filed 2015-03-12 | $156.27M 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | $40.69M 10-Q · filed 2013-11-12 | $40.69M 10-Q · filed 2012-11-09 | $82.06M derived: sum of 2 quarters · filed 2013-11-12 | $123.13M 10-Q · filed 2013-11-12 | $120.14M 10-Q · filed 2012-11-09 | $162.81M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-06-30 | $41.37M 10-Q · filed 2013-08-09 | $40.29M 10-Q · filed 2012-08-08 | $82.44M 10-Q · filed 2013-08-09 | $79.46M 10-Q · filed 2012-08-08 | $122.11M derived: sum of 3 quarters · filed 2014-03-17 | $161.41M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-03-31 | $41.07M 10-Q · filed 2013-08-09 | $39.16M 10-Q · filed 2012-05-10 | $80.74M derived: sum of 2 quarters · filed 2014-03-17 | $120.05M derived: sum of 3 quarters · filed 2014-03-17 | $151.97M derived: sum of 4 quarters · filed 2014-03-17 | |||
| 2011-12-31 | $39.67M derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-03-17 | $78.98M derived: sum of 2 quarters · filed 2014-03-17 | $110.90M derived: sum of 3 quarters · filed 2014-03-17 | $132.56M 10-K · filed 2014-03-17 | $133.64M 10-K · filed 2012-03-15 | |||
| 2011-09-30 | $39.30M 10-Q/A · filed 2013-04-01 | $37.42M 10-Q · filed 2011-11-09 | $71.23M derived: sum of 2 quarters · filed 2013-04-01 | $92.89M 10-Q/A · filed 2013-04-01 | $92.19M 10-Q · filed 2011-11-09 | $116.51M derived: sum of 4 quarters · filed 2013-04-01 | ||
| 2011-06-30 | $31.93M 10-Q/A · filed 2013-04-01 | $33.11M 10-Q · filed 2011-08-09 | $53.59M 10-Q/A · filed 2013-04-01 | $54.77M 10-Q · filed 2011-08-09 | $77.20M derived: sum of 3 quarters · filed 2013-04-01 | $100.04M derived: sum of 4 quarters · filed 2013-04-01 | ||
| 2011-03-31 | $21.66M 10-Q/A · filed 2013-04-01 | $45.28M derived: sum of 2 quarters · filed 2013-04-01 | $68.12M derived: sum of 3 quarters · filed 2013-04-01 | $88.81M derived: sum of 4 quarters · filed 2013-04-01 | ||||
| 2010-12-31 | $23.62M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $46.46M derived: sum of 2 quarters · filed 2013-04-01 | $67.15M derived: sum of 3 quarters · filed 2013-04-01 | $85.11M 10-K · filed 2013-04-01 | ||||
| 2010-09-30 | $22.84M 10-Q · filed 2011-11-09 | $43.53M derived: sum of 2 quarters · filed 2011-11-09 | $61.50M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $20.69M 10-Q · filed 2011-08-09 | $38.66M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $72.41M 10-K · filed 2012-03-15 |